Loxapine VersaFilmTM

Loxapine oral film utilizes IntelGenx' proprietary VersaFilm™ technology to allow for a fast and safe acting loxapine oral film dosage form, offering significant clinical benefits for patients with agitation associated with schizophrenia & bipolar 1 disorder.

Key Licensing Highlights

• The first oral thin film using IntelGenx proprietary drug delivery technology, VersaFilm^TM, for agitation associated with schizophrenia & bipolar1 disorder
• Containing loxapine, a well-known molecule in the antipsychotic drug market
• Fast-acting loxapine oral dosage to treat acute agitation episodes in non-institutionalized patients
• Oral administration of loxapine is associated with reduced risk of pulmonary complications
• Orally disintegrating film, without need for water, packaged in a carry-on-the-go pocket size pouch provides unprecedented patient convenience
• IntelGenx offers strong expertise in formulation and process development as well as manufacturing capability